Webinar held on cancer research

Our Correspondent

Una, Updated At : 08:48 AM Sep 24, 2024 IST

Photo for representational purpose only. File photo

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits

Yearly Premium ₹999 ₹349/Year

Yearly Premium $49 $24.99/Year

An Indian origin scientist, Dr Samir Mehndiratta, today delivered a webinar on his technology to formulate anti-cancer drugs at the Pharmacy Department of KC Polytechnic College at Pandoga village.

He, along with his research associates, have developed drug like molecules capable of targeting two enzymes known to play an important role in development of these brain, spinal cord and prostrate cancer. He is currently working in the University of Technology, Sydney.

College Principal Balwinder Kumar sand Campus Director Vivek Parihar were also present.

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is run by a trust comprising five eminent persons as trustees.

The Tribune, the largest selling English daily in North India, publishes news and views without any bias or prejudice of any kind. Restraint and moderation, rather than agitational language and partisanship, are the hallmarks of the newspaper. It is an independent newspaper in the real sense of the term.

The Tribune has two sister publications, Punjabi Tribune (in Punjabi) and Dainik Tribune (in Hindi).

Remembering Sardar Dyal Singh Majithia

Designed and developed by : SORTD

Unlock Exclusive Insights with The Tribune Premium

Suggested Articles